Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2005-10-04
2005-10-04
Housel, James (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S188100
Reexamination Certificate
active
06951648
ABSTRACT:
A variant of a LAV virus, designated LAVELIand capable of causing AIDS. The cDNA and antigens of the LAVELIvirus can be used for the diagnosis of AIDS and pre-AIDS.
REFERENCES:
patent: 4784941 (1988-11-01), Watanabe et al.
patent: 5034511 (1991-07-01), Alizon et al.
patent: 5156949 (1992-10-01), Luciw et al.
patent: 6337179 (2002-01-01), Alizon et al.
patent: 0 253 701 (1988-01-01), None
Neurath et al., “Radioimmunoassay and Enzyme-Linked Immunoassay of Antibodies Directed Against Lymphadenopathy-Associated Virus (LAV) Proteins Larger Than the Core Protein (P24),” Journal of Virological Methods, 12:85-92 (1985).
Wain-Hobson et al., “Nucleotide Sequence of the AIDS Virus, LAV,” Cell, 40:9-17 (1985).
Wong-Staal et al., “Genomic Diversity of Human T-Lymphotropic Virus Type III (HTLV-III), ” Science, 229:759-762 (1985).
Ellrodt et al., “Isolation of Human T-Lymphotropic Retrovirus (LAV) from Zairian Married Couple, One with AIDS, One with Prodomes, ” The Lancet, 1383-1385 (1984).
Ratner et al., “Complete Nucleotide Sequence of the AIDS Virus, HTLV-III,” Nature, 323:277-284 (1985).
Sanchez-Pescador et al., “Nucleotide Sequence and Expression of an AIDS-Associated Retrovirus (ARV-2),” Science, 227;484-492 (1985).
Muessing et al., “Nucleic Acid Structure and Expression of the Human AIDS/Lymphadenopathy Retrovirus,” Nature, 313:450-458 (1985).
Alizon et al., “Molecule Cloning of Lymphadenopathy-Associated Virus,” Nature, 312:757-760 (1984).
Nature, 313, 277-284 (1985).
Goodenow, et al., J. Acquir, Immune Defic. Syndr., 2:344-352 (1989).
Gao et al., J. Virol., 68:7433-7447 (1994).
Gallo et al., Nature (London) 333:564 (1988).
Myers et al., Eds. Los Alamos Database in Human Retroviruses and AIDS, Los Almos National Laboratory, Nwe Mexico, pp. IA1-IA3 (1990).
Norrby et al., “Type-specific site-directed human immunodeficiency virus serology,” in Vaccines 88, Cold Spring Harbor Laboratory, pp. 335-339 (1988).
Strongin, “Sensitivity, specificity, and predictive value of diagnostic tests: definitions and clinical applications,” in Laboratory Diagnosis of Viral Infections, Lennette, ed., Marcel Dekker, Inc., New York, pp. 211-219 (1992).
Levy, Microbiol. Rev. 57:183-187, 211-213 (1993).
Alizon Marc
Montagnier Luc
Sonigo Pierre
Wain-Hobson Simon
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Housel James
Institut Pasteur
Parkin Jeffrey S.
LandOfFree
Variant of LAV viruses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Variant of LAV viruses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Variant of LAV viruses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3465863